MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

07 Feb 2025 Evaluate
The quarter ended December 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 868.31 millions.Net Profit for the quarter ended December 2024 dipped to Rs. 7.82  millions from Rs. 88.96 millions  in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 37.06 millions from 151.38 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 868.31 848.12 2.38 1748.65 2333.64 -25.07 3289.73 2750.52 19.60
Other Income 1.53 41.88 -96.35 64.20 117.54 -45.38 159.01 76.12 108.89
PBIDT 37.06 151.38 -75.52 162.91 434.35 -62.49 601.94 356.96 68.63
Interest 6.00 2.75 118.18 10.43 8.80 18.52 13.38 11.97 11.78
PBDT 31.06 148.63 -79.10 152.48 425.55 -64.17 588.56 344.99 70.60
Depreciation 22.96 20.67 11.08 44.36 60.83 -27.08 81.48 78.99 3.15
PBT 8.10 127.96 -93.67 108.12 364.72 -70.36 507.08 266.00 90.63
TAX 0.28 39.00 -99.28 22.04 88.02 -74.96 121.89 64.81 88.07
Deferred Tax -11.22 3.85 -391.43 -7.71 6.63 -216.29 7.76 -7.30 -206.30
PAT 7.82 88.96 -91.21 86.08 276.70 -68.89 385.19 201.19 91.46
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 4.27 17.85 -76.09 9.32 18.61 -49.95 18.30 12.98 40.99
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..